-
NuScale might be a lovely power supply as tech giants monitor nuclear power developments.
-
Nevertheless, NuScale is years away from commercialization, which makes it a really dangerous inventory.
-
Axcelis Applied sciences is a contrarian decide on account of its ion implantation expertise. The corporate is shifting its focus from the EV business to AI infrastructure.
NuScale Energy (NYSE: SMR) might fulfill the subsequent wave of synthetic intelligence (AI) power calls for with its small modular reactors. The corporate goals to ship dependable, carbon-free nuclear energy that does not put stress on the facility grid.
The corporate will not be commercialized for a number of years, nevertheless it has made progress with its designs. The U.S. Nuclear Regulatory Fee authorized NuScale’s energy design for a 462-megawatt small modular reactor energy plant final yr, which is a giant benchmark for the corporate.
Nevertheless, your entire thesis relies on NuScale Energy shortly scaling income as soon as it’s commercialized. In the meantime, the inventory trades at a market capitalization of $5.6 billion, which is after it misplaced almost 65% of its worth from its all-time excessive.
You do not have to select a speculative development inventory to journey the AI increase. Axcelis Applied sciences (NASDAQ: ACLS) caters to buyers who aren’t afraid of danger and imagine in comeback tales. It additionally has actual income and earnings, in contrast to NuScale Energy.
Axcelis Applied sciences has elevated by greater than 180% over the previous 5 years, however its shares have additionally declined by greater than 50% from their all-time excessive, which was reached in 2023. Axcelis makes a speciality of ion implantation, a method that produces transistors in electronics. These transistors are important for semiconductors to operate, together with these utilized in AI chips.
Since nearly something associated to AI has skilled sturdy development over the previous few years, it could be stunning to see that Axcelis remains to be effectively beneath its 2023 highs. That is as a result of the corporate’s major income driver was EV demand.
Being a key participant within the EV business labored effectively for Axcelis throughout the COVID-19 pandemic and shortly after it. In lower than three years, Axcelis inventory went from roughly $30 per share to briefly touching $200 per share. That was from 2021 to 2023.
EV gross sales have slowed down since 2023, and Axcelis’ inventory worth actions from mid-2023 to the tip of 2024 replicate this. The expiration of EV tax credit in 2025 made it even worse, however Axcelis nonetheless managed a 16% achieve over the previous yr.
